<DOC>
	<DOCNO>NCT02849483</DOCNO>
	<brief_summary>Ramosetron effective prevent postoperative nausea vomit . Several study report ramosetron also effective treatment irritable bowel syndrome . The investigator examine effect ramosetron postoperative bowel motility .</brief_summary>
	<brief_title>Effect Ramosetron Bowel Motility After Gynecological Surgery</brief_title>
	<detailed_description>Ramosetron , new potent long-acting selective 5-HT3 ( 5-hydroxytryptamine3 ) receptor anatagonist , effective prevent postoperative nausea vomiting . Also several study report ramosetron effective treatment diarrhea-predominant irritable bowel syndrome inhibits accelerate colonic transit , abnormal colonic water transport , defecation abnormality , lower colonic perceptual threshold corticotrophin-releasing hormone , There study effect ramosetron use prevent postoperative nausea vomit postoperative bowel motility . In study , investigator examine effect ramosetron postoperative bowel motility .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Ramosetron</mesh_term>
	<criteria>2070 yrs age ASA ( American Society Anesthesiologists ) physical status class I II Scheduled gynecological laparoscopic surgery Allergic study drug Antiemetics steroid use within 24 hr prior surgery Dependence upon opioids Insulin dependent Diabetes Mellitus Cardiovascular pulmonary disease Renal hepatic insufficiency BMI &gt; =35kg/m2 History motion sickness PONV Cigarette smoker Conversion open laparotomy laparoscopic surgery Pregnants</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>PONV</keyword>
	<keyword>digestive sign symptom</keyword>
	<keyword>vomit</keyword>
	<keyword>antiemetic</keyword>
	<keyword>nausea</keyword>
	<keyword>ramosetron</keyword>
</DOC>